Axon Enterprise (NASDAQ: AXON) chief human officer reports 39,468.65 shares

Rhea-AI Filing Summary

Axon Enterprise, Inc. officer Elizabeth Reid Coughlin, the company's Chief Human Officer, filed an initial ownership report showing her beneficial holdings of the company’s common stock as of January 1, 2026. She reports beneficial ownership of 39,468.65 shares of common stock held directly.

This amount includes 10,287.65 restricted stock units from four time‑vested awards under the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan, with scheduled vesting in installments on specified dates from March 3, 2026 through November 30, 2028. It also includes 6,818 performance-based restricted stock units granted for achievement of tranche 3 of the 2024 eXponential Stock Plan, which are scheduled to vest on June 1, 2026, followed by a minimum holding period extending until at least December 31, 2030 or the vesting of a subsequent tranche. In addition, the holdings include 22,363 shares issued from prior vesting of restricted stock units before January 1, 2026.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Coughlin Elizabeth Reid

(Last) (First) (Middle)

17800 N 85TH ST

(Street)

SCOTTSDALE AZ 85255

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2026

3. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Human Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	39,468.65	D(1)(2)(3)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 10,287.65 restricted stock units subject to vesting conditions related to four separate time-vested awards granted to the reporting person pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. The grants will vest 1,119.48 shares on each of March 3, 2026 and May 31, 2026, 1,118.48 shares on each of August 31, 2026 and November 30, 2026, 802.48 shares on March 3, 2027, 801.48 shares on each of May 31, 2027, August 31, 2027, and November 30, 2027, 651.22 shares on each of March 3, 2028, May 31, 2028, and August 31, 2028, and 651.21 shares on November 30, 2028.

2. Includes 6,818 performance-based restricted stock units granted on December 22, 2023, for the achievement of tranche 3 of the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions were certified by the Compensation Committee on November 13, 2025 as having been met. The restricted stock units will vest on June 1, 2026, subject to continued employment through such date. Following the vesting, the shares are subject to a minimum holding period from the vesting date until the earlier of (i) December 31, 2030 and (ii) the date that a subsequent tranche vests, excluding shares that are withheld or sold to cover taxes.

3. Includes 22,363 shares issued upon the release of time-vested restricted stock units and performance-based restricted stock units prior to January 1, 2026

Remarks:

	Elizabeth Reid Coughlin	01/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Axon Enterprise (AXON) disclose in this Form 3 filing?

The filing reports that Elizabeth Reid Coughlin, Axon Enterprise’s Chief Human Officer, beneficially owns 39,468.65 shares of common stock as of January 1, 2026, held directly.

How many Axon (AXON) shares and units does Elizabeth Reid Coughlin beneficially own?

She beneficially owns 39,468.65 shares of common stock, which include restricted stock units, performance-based restricted stock units, and shares previously issued upon release of such units.

What time-vested restricted stock units are included in the AXON Form 3 for Elizabeth Reid Coughlin?

The holdings include 10,287.65 restricted stock units from four time‑vested awards under the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan, with scheduled vesting in multiple installments from March 3, 2026 through November 30, 2028.

What performance-based awards are reported for Elizabeth Reid Coughlin in Axon (AXON)'s Form 3?

The filing states that her holdings include 6,818 performance-based restricted stock units granted on December 22, 2023 for achievement of tranche 3 of the 2024 eXponential Stock Plan, with performance conditions certified on November 13, 2025 and vesting scheduled for June 1, 2026.

Is there a holding period on Elizabeth Reid Coughlin’s Axon (AXON) performance-based RSUs?

Yes. After the 6,818 performance-based restricted stock units vest on June 1, 2026, the resulting shares are subject to a minimum holding period from that vesting date until the earlier of December 31, 2030 or the date a subsequent tranche vests, excluding shares withheld or sold to cover taxes.

What previously issued shares are included in Elizabeth Reid Coughlin’s AXON beneficial ownership?

The reported holdings include 22,363 shares that were issued upon the release of time‑vested and performance-based restricted stock units prior to January 1, 2026.